Company file Nº 731 / 1000 · Series B · United States · updated 14 Sep 2026
Aqtual
GTM score
30.9
In its stage
217th of 218 Series B
Ranked against 1000 companies indexed as at 14 Sep 2026. The index grows every month, so a rank can move without a company changing.
What they do
Blood tests using cell-free DNA to diagnose and monitor chronic diseases and cancer
The pillar map
exit criteria metexit criteria partly metexit criteria not metno public signal found
The real colors on all 16 pillars, with each pillar's score, free with an email address.
Our read
We read every map the same way: where the engine is strong, where it's stuck, and what matters most next. Our read on Aqtual: our read, unlocks with email
What the full report adds
GTM score over time
Think we got Aqtual wrong? and we will take another look. How we score →